<?xml version='1.0' encoding='UTF-8'?>
<pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="review-article">
  <?properties open_access?>
  <processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
    <restricted-by>pmc</restricted-by>
  </processing-meta>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Nat Sci Sleep</journal-id>
      <journal-id journal-id-type="iso-abbrev">Nat Sci Sleep</journal-id>
      <journal-id journal-id-type="publisher-id">nss</journal-id>
      <journal-title-group>
        <journal-title>Nature and Science of Sleep</journal-title>
      </journal-title-group>
      <issn pub-type="epub">1179-1608</issn>
      <publisher>
        <publisher-name>Dove</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">36045914</article-id>
      <article-id pub-id-type="pmc">9423119</article-id>
      <article-id pub-id-type="publisher-id">374572</article-id>
      <article-id pub-id-type="doi">10.2147/NSS.S374572</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Review</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Impact of Desaturation Patterns versus Apnea–Hypopnea Index in the Development of Cardiovascular Comorbidities in Obstructive Sleep Apnea Patients</article-title>
        <alt-title alt-title-type="running-authors">Blekic et al</alt-title>
        <alt-title alt-title-type="running-title">Blekic et al</alt-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Blekic</surname>
            <given-names>Nathan</given-names>
          </name>
          <xref rid="aff0001" ref-type="aff">
<sup>1</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Bold</surname>
            <given-names>Ionela</given-names>
          </name>
          <xref rid="aff0001" ref-type="aff">
<sup>1</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Mettay</surname>
            <given-names>Thomas</given-names>
          </name>
          <xref rid="aff0002" ref-type="aff">
<sup>2</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Bruyneel</surname>
            <given-names>Marie</given-names>
          </name>
          <xref rid="aff0001" ref-type="aff">
<sup>1</sup>
</xref>
          <xref rid="aff0002" ref-type="aff">
<sup>2</sup>
</xref>
          <xref rid="an0001" ref-type="corresp"/>
        </contrib>
        <aff id="aff0001"><label>1</label><institution>Department of Pulmonary Medicine, Saint-Pierre University Hospital, Brussels, Belgium and Université Libre de Bruxelles</institution>, <addr-line>Brussels</addr-line>, <country>Belgium</country></aff>
        <aff id="aff0002"><label>2</label><institution>Department of Pulmonary Medicine, Brugmann University Hospital, Brussels, Belgium and Université Libre de Bruxelles</institution>, <addr-line>Brussels</addr-line>, <country>Belgium</country></aff>
      </contrib-group>
      <author-notes>
        <corresp id="an0001">Correspondence: Marie Bruyneel, <institution>Department of Pulmonary Medicine, Saint-Pierre University Hospital</institution>, <addr-line>Rue Haute, 322</addr-line>, <addr-line>Brussels</addr-line>, <addr-line>1000</addr-line>, <country>Belgium</country>, <phone>Tel +322 5354219</phone>, Fax: <fax>+322 5353362</fax>, Email marie.bruyneel@stpierre-bru.be</corresp>
      </author-notes>
      <pub-date pub-type="epub">
        <day>25</day>
        <month>8</month>
        <year>2022</year>
      </pub-date>
      <pub-date pub-type="collection">
        <year>2022</year>
      </pub-date>
      <volume>14</volume>
      <fpage>1457</fpage>
      <lpage>1468</lpage>
      <history>
        <date date-type="received">
          <day>14</day>
          <month>5</month>
          <year>2022</year>
        </date>
        <date date-type="accepted">
          <day>15</day>
          <month>8</month>
          <year>2022</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>© 2022 Blekic et al.</copyright-statement>
        <copyright-year>2022</copyright-year>
        <copyright-holder>Blekic et al.</copyright-holder>
        <license>
          <ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbynclicense">https://creativecommons.org/licenses/by-nc/3.0/</ali:license_ref>
          <license-p>This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at <ext-link ext-link-type="uri" xlink:href="https://www.dovepress.com/terms.php">https://www.dovepress.com/terms.php</ext-link> and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc/3.0/">http://creativecommons.org/licenses/by-nc/3.0/</ext-link>). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (<ext-link ext-link-type="uri" xlink:href="https://www.dovepress.com/terms.php">https://www.dovepress.com/terms.php</ext-link>).</license-p>
        </license>
      </permissions>
      <abstract>
        <title>Abstract</title>
        <p><citation_analysis attribute="positive">Various phenotypes of obstructive sleep apnea (OSA) have been recently described and are poorly assessed by the commonly used polysomnographic indices, such as the apnea–hypopnea index and oxygen desaturation index. Nocturnal hypoxemia is the hallmark of OSA and new quantitative markers, as hypoxic burden or desaturation severity, have been shown to be associated with cardiovascular (CV) mortality. The purpose of this overview is to review the endophenotypical and clinical characteristics of OSA, the current metrics, and to analyze different measurements of hypoxemia in OSA to predict the cardiovascular impact (eg hypoxic burden). Potential interest of multidimensional models to classify OSA, such as BAVENO classification, is also discussed, with the goal of focusing on specific endophenotypes that are likely to develop CV comorbidities, in order to guide clinicians to more aggressive management of OSA in these individuals.</citation_analysis></p>
      </abstract>
      <kwd-group kwd-group-type="author">
        <title>Keywords</title>
        <kwd>obstructive sleep apnea</kwd>
        <kwd>oxygen desaturation index</kwd>
        <kwd>hypoxic burden</kwd>
        <kwd>apnea–hypopnea index</kwd>
        <kwd>polysomnography</kwd>
        <kwd>home sleep apnea testing</kwd>
      </kwd-group>
      <counts>
        <fig-count count="3"/>
        <table-count count="2"/>
        <ref-count count="76"/>
        <page-count count="12"/>
      </counts>
    </article-meta>
  </front>
  <body>
    <sec sec-type="intro" id="s0001">
      <title>Introduction</title>
      <p><citation_analysis attribute="neither">Obstructive sleep apnea (OSA) syndrome is a common medical disorder, characterized by recurrent episodes of apnea or hypopnea due to total or partial pharyngeal collapse and temporary upper airway (UA) obstruction during sleep. The prevalence of OSA is increasing, due to obesity and aging, and currently affects about 30% of men and 13% of women in Europe.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0001" ref-type="bibr">1</xref></citation_analysis><citation_analysis attribute="negative"> Intermittent hypoxia (IH), oxidative stress, systemic inflammation, sympathetic activation, respiratory efforts, and sleep fragmentation resulting from OSA can provoke subsequent cardiometabolic disorders, such that OSA is now recognized as an independent risk factor for hypertension (HT), arrhythmia (as atrial fibrillation), coronary heart disease (CHD), and stroke.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0002" ref-type="bibr">2–6</xref></citation_analysis><citation_analysis attribute="neither"> In addition, metabolic disorders (eg, diabetes mellitus (DM), disorders of lipid metabolism) are also associated with OSA.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0007" ref-type="bibr">7</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0008" ref-type="bibr">8</xref></citation_analysis><citation_analysis attribute="positive"> Continuous positive airway pressure (CPAP) treatment remains the cornerstone of OSA treatment.</citation_analysis></p>
      <p><citation_analysis attribute="neither">OSAS (OSA syndrome) diagnosis is based on criteria that combine symptoms, comorbidities, and polysomnographic (PSG) recordings that indicate the presence of obstructive respiratory events.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0009" ref-type="bibr">9</xref></citation_analysis><citation_analysis attribute="neither"> In-lab PSG continues to be the reference diagnostic method,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0010" ref-type="bibr">10</xref></citation_analysis><citation_analysis attribute="neither"> but home sleep apnea testing (HSAT) has become widely accepted and can be used for OSA diagnosis in patients with a high pre-test probability of moderate-to-severe OSA.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0011" ref-type="bibr">11</xref></citation_analysis><citation_analysis attribute="negative"> Practically, despite some limitations (ie, lack of electroencephalogram [EEG] means correct assessment of total sleep time [TST] and arousals is not possible), HSAT is used worldwide and is reimbursed in the United States and in the majority of European countries (eg, Spain, France, Germany) for OSA diagnosis. HSAT increases the accessibility of sleep testing and hastens treatment initiation, but some comorbid disorders can be missed, such as insomnia which is very prevalent in OSA.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0012" ref-type="bibr">12</xref></citation_analysis></p>
      <p><citation_analysis attribute="neither">Polysomnographic assessment of OSA is based on a number of different metrics. Apnea–hypopnea index (AHI) is the central metric for OSA assessment. The definition of AHI is the number of hypopneas + apnea/hour of sleep (or recording time). Obstructive apneas are respiratory events classified by a complete cessation (defined as a decrease in amplitude of &gt; 90%) of airflow for at least 10 seconds together with continued respiratory effort. A hypopnea is similar to an apnea, although the decrease in airflow is 30%–90% in amplitude and associated with &gt;3% oxygen desaturation or EEG arousal.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0009" ref-type="bibr">9</xref></citation_analysis><citation_analysis attribute="neither"> In the past, other definitions have been used. For example, in American Academy of Sleep Medicine (AASM) scoring rules of 2007, hypopnea was defined as decrease in airflow is 30%–90% in amplitude associated with &gt;4% oxygen desaturation.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0013" ref-type="bibr">13</xref></citation_analysis></p>
      <p><citation_analysis attribute="neither">The severity of OSA is expressed according to obstructive AHI values of 5–14, 15–29, &gt; 30 events/h of TST that define, respectively, mild, moderate, and severe OSA. Although there is a linear relationship between AHI and blood pressure (BP)</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0014" ref-type="bibr">14</xref></citation_analysis><citation_analysis attribute="neither"> and AHI correlates with overall mortality in OSA patients,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0015" ref-type="bibr">15</xref></citation_analysis><citation_analysis attribute="neither"> AHI is poorly correlated with the severity of clinical symptoms.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0016" ref-type="bibr">16</xref></citation_analysis></p>
      <p><citation_analysis attribute="positive">With the development of HSAT and the awareness of the limits of AHI measurements, other metrics have been developed to describe OSA. Oxygen desaturation index (ODI) represents the number of occurrences of desaturation (3% or 4%)/hour of sleep (or recording time). It does not necessarily mean that oxygen saturation falls below 90%: drops from 96 to 92% are often observed. Data from the European Sleep Apnoea Database (ESADA) have shown that when both AHI and ODI are used in the same statistical model, only ODI is independently associated with the prevalence of HT in OSA patients.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0017" ref-type="bibr">17</xref></citation_analysis><citation_analysis attribute="neither"> However, ODI does not assess the length of oxygen desaturation consecutive to an obstructive apnea or hypopnea. Thus, there are limitations to the ability of these two parameters to assess all the aspects of OSA.</citation_analysis></p>
      <p><citation_analysis attribute="positive">This is likely to be related to heterogeneity of OSA. The clinical picture of OSA is heterogeneous and can differ widely among patients. In the last decade, a variety of clinical phenotypes have been identified, highlighting clusters with different symptomologies and comorbidities in patients affected by the “same disease” when described in terms of AHI severity.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0018" ref-type="bibr">18</xref></citation_analysis><citation_analysis attribute="positive"> Indeed, AHI is still the indicator used to classify disease severity and guide treatment, but its usefulness is limited for capturing the full clinical picture of OSA. For example, among patients with the same AHI, some exhibit long apneas with profound oxygen desaturation, and others exhibit very short apneas without significant associated hypoxia. These differences can potentially lead to several clinical OSA phenotypes for which identical management strategies may not be optimal. Moreover, additional pathophysiological processes generated by obstructive respiratory events can overlay intermittent hypoxia (IH) and are observed in the development of symptoms or comorbidities, such as sympathetic activation, systemic inflammation, oxidative stress, sleep fragmentation, and respiratory efforts.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0019" ref-type="bibr">19</xref></citation_analysis></p>
      <p><citation_analysis attribute="negative">Several studies have identified different phenotypes of OSA patients. For example, in an analysis of 18,263 OSA patients in the OSFP (French national registry of sleep apnea), Bailly et al found six phenotypes based on baseline symptoms, physical examination, risk factor exposure, and comorbidities: young symptomatic patients, young snorers, drowsy obese, older obese, polypathological symptomatic obese, and polypathological old obese.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0020" ref-type="bibr">20</xref></citation_analysis></p>
      <p><citation_analysis attribute="neither">In a recent review of cluster studies among OSA patients, Zinchuk and Yaggi proposed six clusters (A, B, C, D, E, F) of patients according to phenotypical and clinical criteria and PSG characteristics. Response to CPAP was also analyzed.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0018" ref-type="bibr">18</xref></citation_analysis><citation_analysis attribute="negative"> Subtype A includes younger, obese, predominantly male individuals with severe OSA, “classic” symptoms (eg, sleepiness, drowsy driving) and an increased risk of incident cardiovascular disease (CVD) (hazard ratio [HR]: 2.0, [95% CI:1.21–3.31]). Subtype B consists of predominantly male, older, obese individuals with minimal to moderate symptom burden, severe OSA with marked hypoxemic burden (time spent below 90% of oxygen [T90%]: 32%-59% of TST),</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0018" ref-type="bibr">18</xref></citation_analysis><citation_analysis attribute="neither"> frequent comorbidities (HT, DM, and CVD), related to both age and hypoxia.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0015" ref-type="bibr">15</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0021" ref-type="bibr">21</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0022" ref-type="bibr">22</xref></citation_analysis><citation_analysis attribute="neither"> These patients exhibit the lowest rate of CPAP success,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0023" ref-type="bibr">23</xref></citation_analysis><citation_analysis attribute="neither"> although fatigue and obstructive respiratory events are improved with CPAP. Subtype C includes middle-aged, mildly obese, predominantly female subjects with symptoms of insomnia.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0018" ref-type="bibr">18</xref></citation_analysis><citation_analysis attribute="neither"> CPAP adherence is lower in the “comorbid OSA with insomnia” group than in patients with OSA alone. Maintenance insomnia responds better to CPAP than other subtypes of insomnia. Subtype D includes younger, non-obese, non-sleepy, predominantly male patients with primarily upper airway (UA) symptoms and severe AHI values.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0018" ref-type="bibr">18</xref></citation_analysis><citation_analysis attribute="neither"> Adherence to CPAP is low (odds ratio (OR): 0.66). Subtype E, based on PSG metrics, includes patients with hypersevere OSA (AHI 66–84/hour of sleep), the highest body mass indices (BMI) (33–38 kg/m</citation_analysis><citation_analysis attribute="positive"><sup>2</sup></citation_analysis><citation_analysis attribute="negative">), the most marked hypoxemia (T90%:20%–45%), and the highest Epworth Sleepiness Scale (ESS) scores among the clusters. These patients exhibited an increased risk of incident CVD or death (HR 1.91 [95% CI:1.27–2.85]). Finally, subtype F, which is the second most common PSG phenotype, includes patients with severe OSA, low BMI, and the lowest degree of hypoxemia for a given AHI (T90%: 0%–12%). They exhibited the lowest rate of regular CPAP use (29%) among clusters with AHI &gt; 15.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0018" ref-type="bibr">18</xref></citation_analysis></p>
      <p><citation_analysis attribute="neither">These various phenotypes illustrate the marked heterogeneity of the disease within the patients. Response to CPAP (clinical benefit and/or impact on comorbidities) is also highly variable. OSA phenotypes are summarized in </citation_analysis><citation_analysis attribute="positive"><xref rid="t0001" ref-type="table">Table 1</xref></citation_analysis><citation_analysis attribute="neither">.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0018" ref-type="bibr">18</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0020" ref-type="bibr">20</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0023" ref-type="bibr">23</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0024" ref-type="bibr">24</xref></citation_analysis><citation_analysis attribute="positive"><table-wrap position="float" id="t0001"><label>Table 1</label><caption><p><citation_analysis attribute="neither">OSA Phenotypes According to Demographics, Symptoms, PSG Pattern, CPAP Benefit and Comorbidities.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0018" ref-type="bibr">18</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0020" ref-type="bibr">20</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0023" ref-type="bibr">23</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0024" ref-type="bibr">24</xref></citation_analysis></p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2" colspan="1"/><th rowspan="1" colspan="1">A</th><th rowspan="1" colspan="1">B</th><th rowspan="1" colspan="1">C</th><th rowspan="1" colspan="1">D</th><th rowspan="1" colspan="1">E</th><th rowspan="1" colspan="1">F</th></tr><tr><th rowspan="1" colspan="1">Classic</th><th rowspan="1" colspan="1">Oldest Comorbid</th><th rowspan="1" colspan="1">Female, Insomnia</th><th rowspan="1" colspan="1">Youngest, Upper Airways Symptoms</th><th rowspan="1" colspan="1">Severe Hypoxemic</th><th rowspan="1" colspan="1">Severe Non-Hypoxemic</th></tr></thead><tbody><tr><td rowspan="1" colspan="1"><bold>Age</bold></td><td rowspan="1" colspan="1">Younger</td><td rowspan="1" colspan="1">Oldest</td><td rowspan="1" colspan="1">Middle</td><td rowspan="1" colspan="1">Youngest</td><td rowspan="1" colspan="1">Younger</td><td rowspan="1" colspan="1">Older</td></tr><tr><td rowspan="1" colspan="1"><bold>Predominant sex</bold></td><td rowspan="1" colspan="1">♂</td><td rowspan="1" colspan="1">♂</td><td rowspan="1" colspan="1">♀</td><td rowspan="1" colspan="1">♂</td><td rowspan="1" colspan="1">♂</td><td rowspan="1" colspan="1">♂</td></tr><tr><td rowspan="1" colspan="1"><bold>BMI</bold></td><td rowspan="1" colspan="1">Obese</td><td rowspan="1" colspan="1">Obese</td><td rowspan="1" colspan="1">Overweight-Obese</td><td rowspan="1" colspan="1">Non Obese</td><td rowspan="1" colspan="1">Severely Obese</td><td rowspan="1" colspan="1">Obese</td></tr><tr><td rowspan="1" colspan="1"><bold>Symptoms</bold></td><td rowspan="1" colspan="1">EDS</td><td rowspan="1" colspan="1">Naps</td><td rowspan="1" colspan="1">Insomnia</td><td rowspan="1" colspan="1">Choking + Insomnia</td><td rowspan="1" colspan="1">EDS</td><td rowspan="1" colspan="1">Less sleepy</td></tr><tr><td rowspan="1" colspan="1"><bold>PSG pattern</bold></td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"> <bold>AHI</bold></td><td rowspan="1" colspan="1">Severe</td><td rowspan="1" colspan="1">Severe</td><td rowspan="1" colspan="1">Moderate-Severe</td><td rowspan="1" colspan="1">Severe</td><td rowspan="1" colspan="1">Hypersevere</td><td rowspan="1" colspan="1">Severe</td></tr><tr><td rowspan="1" colspan="1"> <bold>Time spent &lt;90% Sa02</bold></td><td rowspan="1" colspan="1">Medium</td><td rowspan="1" colspan="1">32–59%</td><td rowspan="1" colspan="1">Medium</td><td rowspan="1" colspan="1">10–15%</td><td rowspan="1" colspan="1">20–45%</td><td rowspan="1" colspan="1">&lt;12%</td></tr><tr><td rowspan="1" colspan="1"><bold>Comorbidities</bold></td><td rowspan="1" colspan="1">-</td><td rowspan="1" colspan="1">++</td><td rowspan="1" colspan="1">±</td><td rowspan="1" colspan="1">–</td><td rowspan="1" colspan="1">NA</td><td rowspan="1" colspan="1">NA</td></tr><tr><td rowspan="1" colspan="1"><bold>Benefit of CPAP</bold></td><td rowspan="1" colspan="1">Highest</td><td rowspan="1" colspan="1">Lowest</td><td rowspan="1" colspan="1">Medium</td><td rowspan="1" colspan="1">Medium</td><td rowspan="1" colspan="1">High</td><td rowspan="1" colspan="1">Medium</td></tr><tr><td rowspan="1" colspan="1"><bold>Incidence CVD</bold></td><td rowspan="1" colspan="1">+</td><td rowspan="1" colspan="1">-</td><td rowspan="1" colspan="1">NA</td><td rowspan="1" colspan="1">NA</td><td rowspan="1" colspan="1">+</td><td rowspan="1" colspan="1">NA</td></tr></tbody></table><table-wrap-foot><fn id="tfn0001"><p><citation_analysis attribute="positive"><bold>Abbreviations</bold></citation_analysis><citation_analysis attribute="positive">: BMI, body mass index; PSG, polysomnographic; SaO2, oxygen saturation; CPAP, continuous positive airway pressure; EDS, excessive daytime sleepiness; NA, not assessed; CVD, cardiovascular disease; ♂, male; ♀, female.</citation_analysis></p></fn></table-wrap-foot></table-wrap></citation_analysis><citation_analysis attribute="positive">
</citation_analysis></p>
      <p><citation_analysis attribute="negative">Each OSA phenotype is ultimately the clinical expression of several endotypes, subtypes of OSA defined by a unique or distinctive functional or pathophysiological mechanism (eg UA muscle activity, obesity, arousal threshold, …). A better understanding of the specificities of each OSA endophenotype, from pathophysiological mechanisms to clinical expression (PSG, symptoms, comorbidities) seems essential today to detect OSA patients at risk of CVD for early intensive management.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0025" ref-type="bibr">25</xref></citation_analysis></p>
      <p><citation_analysis attribute="positive">In all of these OSA clusters/subtypes, AHI is not correlated with the symptoms and daytime sleepiness, assessed by ESS, is also not present in all phenotypes (</citation_analysis><citation_analysis attribute="positive"><xref rid="t0001" ref-type="table">Table 1</xref></citation_analysis><citation_analysis attribute="neither">).</citation_analysis></p>
      <p><citation_analysis attribute="neither">With regard to these data, AHI metrics exhibit several obvious limitations.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0026" ref-type="bibr">26</xref></citation_analysis><citation_analysis attribute="neither"> The first is related to the validity of the metric itself, which is based on older studies and on sensors that have changed over time.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0016" ref-type="bibr">16</xref></citation_analysis><citation_analysis attribute="neither"> The definition of hypopnea has also changed since the first definition from the AASM in 1999 and significantly affects the association between OSA severity and comorbidities. Indeed, in 2007 AASM scoring rules, hypopnea was defined as a decrease in airflow is 30%–90% in amplitude associated with &gt;4% oxygen desaturation.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0013" ref-type="bibr">13</xref></citation_analysis><citation_analysis attribute="positive"> The difference between AASM 2007 and 2012 definitions (4% vs 3% or EEG arousal) has led to an important underestimation of OSA diagnosis when using the AASM 2007 scoring rules, resulting in the absence of association between HT and severe OSA when using this too stringent definition.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0027" ref-type="bibr">27</xref></citation_analysis><citation_analysis attribute="neither"> The change in definition of hypopnea over time is important to consider when analyzing studies.</citation_analysis></p>
      <p><citation_analysis attribute="neither">In addition, AHI is not well correlated with symptoms</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0028" ref-type="bibr">28</xref></citation_analysis><citation_analysis attribute="neither"> or with comorbidities,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0029" ref-type="bibr">29</xref></citation_analysis><citation_analysis attribute="neither"> and does not consider the amount of hypoxemia provoked by obstructive respiratory events, the length of the events, and other pathophysiological consequences.</citation_analysis></p>
      <p><citation_analysis attribute="positive">Another problem is the use of a single-night estimate of OSA severity using AHI metrics when there is certainly night-to-night variability. A recent study based on data from collection of 11.6 million nights of data from over 65,000 patients, although collected with a mattress sensor (Withings Sleep Analyzer), showed that the likelihood of misdiagnosis in patients suffering from OSA based on a single night ranged between approximately 20% and 50%.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0030" ref-type="bibr">30</xref></citation_analysis></p>
      <p><citation_analysis attribute="neither">In a study from André et al.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0031" ref-type="bibr">31</xref></citation_analysis><citation_analysis attribute="negative"> AHI, apnea–hypopnea (AH) duration, reduced sleep efficiency and TST, low rapid eye movement (REM) sleep proportion, and nocturnal hypoxemia were identified as risk factors associated with all cardiovascular (CV) complications. There was a strong association between OSA severity, reflected by AHI and the presence of cardiometabolic comorbidities that share the same pathophysiological mechanisms. They also highlighted that mean duration of AH in REM and non-REM sleep is an independent predictor of the presence of cardiometabolic comorbidities. Wu et al,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0032" ref-type="bibr">32</xref></citation_analysis><citation_analysis attribute="neither"> have shown, in a retrospective study, that a longer mean AH duration (but not AHI) is associated with higher odds of moderate-to-severe HT. Mokhlesi et al have shown, in the very large Wisconsin sleep Cohort, that in individuals with non-REM AHI &lt; 5, a twofold increase in REM AHI was associated with 24% higher odds of HT.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0033" ref-type="bibr">33</xref></citation_analysis></p>
      <p><citation_analysis attribute="neither">These observations suggest that AHI is an oversimplified measure of OSA that does not take into account the parameters related to nocturnal hypoxemia.</citation_analysis></p>
      <p><citation_analysis attribute="positive">Nighttime hypoxemia is effectively a very interesting parameter to explore, as IH is the hallmark of OSA. Several observational studies have demonstrated that measures of nocturnal hypoxemia, such as T90%, more strongly predict CVD, postoperative complications and all-cause mortality than AHI.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0034" ref-type="bibr">34–36</xref></citation_analysis></p>
      <p><citation_analysis attribute="neither">In the following chapter, we will explore the use of these metrics in the assessment of OSA.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0037" ref-type="bibr">37</xref></citation_analysis></p>
      <p><citation_analysis attribute="neither">The purpose of this review is to summarize the endophenotypic and clinical features of OSA, current measures of OSA, and to analyze different measures of hypoxemia that could help predict cardiovascular impact.</citation_analysis></p>
      <p><citation_analysis attribute="neither">The potential value of multidimensional models to classify OSA will also be discussed.</citation_analysis></p>
    </sec>
    <sec id="s0002">
      <title>Exploring Nocturnal Hypoxemia</title>
      <sec id="s0002-s2001">
        <title>Patterns of Nocturnal Hypoxemia</title>
        <p><citation_analysis attribute="neither">Two patterns of hypoxemia can be observed during sleep: short intermittent high-frequency hypoxemia, as seen in OSA, and prolonged low-frequency hypoxemia as seen in chronic obstructive pulmonary disease (COPD) or at high altitude. The major difference is the cycles of reoxygenation. The cyclical changes in hypoxemia and reoxygenation are similar to those observed with an ischemia-reperfusion injury and contribute to an increased production of reactive oxygen species (ROS) and oxidative stress through NF-κB and, in lesser way, hypoxia-inducible factor (HIF).</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0038" ref-type="bibr">38</xref></citation_analysis><citation_analysis attribute="neither"> Chronic continuous hypoxemia leads to increased erythropoiesis and pulmonary HT, by adaptive and maladaptive responses of HIF. Prolonged sustained hypoxemia leads however to HIF-1α decay, but this is not observed in case of chronic HI. In this situation, imbalance between HIF-1α and HIF-2α contributes to oxidative stress.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0039" ref-type="bibr">39</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0040" ref-type="bibr">40</xref></citation_analysis></p>
      </sec>
      <sec id="s0002-s2002">
        <title>Pathophysiological Consequences of Nocturnal Hypoxia</title>
        <p><citation_analysis attribute="positive">Two main mechanisms are triggered by IH. On the one hand, sympathetic activation has important effects on vascular function. Activation of the sympathetic nervous system leads to vasoconstriction and elevates blood pressure by increasing vascular resistance and is a major contributing factor for OSA-associated hypertension (</citation_analysis><citation_analysis attribute="positive"><xref rid="f0001" ref-type="fig">Figure 1</xref></citation_analysis><citation_analysis attribute="neither">). One the other hand, several inflammatory pathways are triggered by IH and can eventually lead to tumor growth, dyslipidemia and endothelial dysfunction (</citation_analysis><citation_analysis attribute="positive"><xref rid="f0001" ref-type="fig">Figure 1</xref></citation_analysis><citation_analysis attribute="neither">).</citation_analysis><citation_analysis attribute="positive"><fig position="float" id="f0001" fig-type="figure"><label>Figure 1</label><caption><p><citation_analysis attribute="neither">Illustration of the pathophysiological consequences of intermittent hypoxia in obstructive sleep apnea (OSA).</citation_analysis></p></caption><graphic xlink:href="NSS-14-1457-g0001" content-type="print-only" position="float"/><attrib><bold>Abbreviations</bold>: CRP, C-reactive protein; eNOS, endothelial nitric oxide synthase; HIF, hypoxia-inducible factor; NADPH, nicotinamide adenine dinucleotide phosphate hydrogen; RNS, reactive nitrogen species; ROS, reactive oxygen species; SREBP1, sterol regulatory element-binding protein 1, SCD-1, stearoyl-CoA desaturase-1; TNF-α, tumor necrosis factor, VEGF; vascular epithelial growth factor.</attrib></fig></citation_analysis></p>
        <p><citation_analysis attribute="neither">IH induces also metabolic consequences via an increased activity of HIF-1 triggered by the carotid body. HIF-1 causes upregulation of lipid biosynthesis in the liver, increases in adipose tissue lipolysis with subsequent free fatty acid flux to the liver, and inhibition of lipoprotein clearance. All these mechanisms can contribute to dyslipidemia and thus indirectly to atherosclerosis.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0041" ref-type="bibr">41</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0042" ref-type="bibr">42</xref></citation_analysis></p>
        <p><citation_analysis attribute="neither">Tumor growth, dyslipidemia and endothelial dysfunction are mediated by systemic inflammation, endothelin release, and attenuated production of nitric oxide (NO).</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0043" ref-type="bibr">43</xref></citation_analysis></p>
        <p><citation_analysis attribute="neither">Hypoxemia is an important trigger for endothelial cell endothelin production,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0044" ref-type="bibr">44</xref></citation_analysis><citation_analysis attribute="positive"> a highly potent vasoconstrictor, and untreated OSA results in elevation of both endothelin and BP, reversible with CPAP treatment, and for levels of circulating NO, which normalize. These hypoxemia-driven effects on systemic inflammation, endothelin, and NO are likely to contribute to the marked endothelial dysfunction present in patients with OSA.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0039" ref-type="bibr">39</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0045" ref-type="bibr">45</xref></citation_analysis></p>
        <p><citation_analysis attribute="neither">However, systemic inflammation observed in OSA patients is not only related to IH but also to obesity. Indeed, abdominal obesity is associated with low grade systemic inflammation (increased levels of C-reactive protein [CRP] and interleukin [IL]-6) and inflammatory changes in adipose tissue.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0046" ref-type="bibr">46–48</xref></citation_analysis></p>
        <p><citation_analysis attribute="neither">An increase in leptin levels is also observed, inducing a central stimulation of ventilation through crossing of blood–brain barrier.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0049" ref-type="bibr">49</xref></citation_analysis></p>
        <p><citation_analysis attribute="positive">Then, as obesity increases (BMI&gt;40Kg/m2), the patient may develop obesity-hypoventilation syndrome (OHS) which leads to daytime hypercapnia through central leptin resistance. This resistance increases leptin levels again, compared to obese patients without hypercapnia. However, there is no resistance to the peripheral effects of leptin, which leads to increased sympathetic activity and cytokine production. In addition, work of breathing is higher in OHS than in obese. This leads to increased pro-inflammatory cytokine RANTE-5 (involved in atherosclerosis), decreased anti-inflammatory adipokine, and altered endothelial function.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0050" ref-type="bibr">50</xref></citation_analysis></p>
        <p><citation_analysis attribute="neither">One factor however, the tumor necrosis factor (TNF-α) does not seem to be influenced by obesity. Indeed, in OSA patients, TNF-α level is elevated in comparison to controls, independently of obesity, age and sleepiness. The level is correlated with the severity of OSA, and the best predictor of TNF-α levels is ODI.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0038" ref-type="bibr">38</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0051" ref-type="bibr">51</xref></citation_analysis></p>
      </sec>
      <sec id="s0002-s2003">
        <title>Impact of Intermittent Hypoxia in the Development of Cardiometabolic Comorbidities</title>
        <p><citation_analysis attribute="neither">IH drives chemoreflex stimulation, leading to vasoconstriction via sympathetic activation, which plays an important in the development of CV comorbidities. This can be attenuated by stretching of the thoracic afferents and is thus more marked during apnea than during hypopnea.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0039" ref-type="bibr">39</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0052" ref-type="bibr">52</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0053" ref-type="bibr">53</xref></citation_analysis><citation_analysis attribute="neither"> Recurrent cortical arousals also contribute to sympathetic activation. Patients with OSA retain very high levels of sympathetic activation during normoxic daytime wakefulness, comparable to patients with heart failure. When they receive 100% oxygen therapy, this lowers their sympathetic drive, BP, and heart rate, suggesting that tonic chemoreflex activation is a contributor to sustained sympathetic drive.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0052" ref-type="bibr">52</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0053" ref-type="bibr">53</xref></citation_analysis><citation_analysis attribute="neither"> Moreover, the primary response to hypoxemia is bradycardia, as is seen in the diving reflex. Varying degrees of bradycardia and bradyarrhythmias are seen in patients with OSA which, in some patients, may manifest as Mobitz II, complete heart block, and sinus arrest.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0054" ref-type="bibr">54</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0055" ref-type="bibr">55</xref></citation_analysis><citation_analysis attribute="neither"> Atrial fibrillation is very prevalent in OSA patients,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0005" ref-type="bibr">5</xref></citation_analysis><citation_analysis attribute="neither"> and is related to structural and electrical remodeling in the atria caused by increase of both vagal and sympathetic activity.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0056" ref-type="bibr">56</xref></citation_analysis></p>
        <p><citation_analysis attribute="positive">Multiple studies have demonstrated associations between IH and indices of subclinical CVD or CVD risk factors, including endothelial dysfunction, increased sympathetic activation, inflammation, oxidative stress, and metabolic dysfunction.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0052" ref-type="bibr">52</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0057" ref-type="bibr">57</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0058" ref-type="bibr">58</xref></citation_analysis><citation_analysis attribute="neither"> The pathophysiological consequences of IH are summarized in </citation_analysis><citation_analysis attribute="positive"><xref rid="f0001" ref-type="fig">Figure 1</xref></citation_analysis><citation_analysis attribute="neither">.</citation_analysis></p>
        <p><citation_analysis attribute="positive">Prognostic biomarkers of IH could be useful to identify patients who suffer the most, or are most likely to suffer from cellular or tissue hypoxic injury related to IH and related oxidative stress. However, to date, even if several promising biomarkers have been identified (Specific MicroRNAs related to hypoxia, IL-6, IL-8, high-sensitivity CRP, TNF-α, homocysteine, cysteine ….), none are enough sensitive and specific to predict individual susceptibility to CV morbidity.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0059" ref-type="bibr">59</xref></citation_analysis><citation_analysis attribute="neither"> Similarly, none of the markers of oxidative stress (eg thiobarbituric acid reactive substances; malondialdehyde; serum paraoxonase 1; catalase; glutathione peroxidase; superoxide dismutase) are currently able to discriminate from OSA patients with and without CV complications.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0060" ref-type="bibr">60</xref></citation_analysis><citation_analysis attribute="negative"> The lack of specificity and obesity, as a major confounder, remain the major barriers to use in clinical practice. Further studies are needed to identify specific endophenotypes susceptible to develop CV comorbidities, in order to guide clinicians for more aggressive OSA management in these individuals.</citation_analysis></p>
      </sec>
      <sec id="s0002-s2004">
        <title>Oxygen Desaturation Measurements</title>
        <p><citation_analysis attribute="positive">Hypoxemia appears to significantly impact the occurrence of CV and cardiometabolic comorbidities. For example, ODI 4% was shown to be associated with HT,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0017" ref-type="bibr">17</xref></citation_analysis><citation_analysis attribute="neither"> and T90% with HT and cerebro/CV diseases.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0061" ref-type="bibr">61</xref></citation_analysis></p>
        <p><citation_analysis attribute="neither">But, as we have already discussed for AHI, ODI metrics exhibit limits. For example, a patient with an ODI of 15/hour of sleep but with long oxygen desaturation episodes can have a two-fold higher T90% and a lower minimal saturation than a patient with an ODI of 35/hour of sleep but shorter events, associated with light levels of oxygen desaturation.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0062" ref-type="bibr">62</xref></citation_analysis></p>
        <p><citation_analysis attribute="neither">To overcome these limitations, a new metric was proposed by Azarbarzin et al to measure hypoxic burden.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0063" ref-type="bibr">63</xref></citation_analysis><citation_analysis attribute="positive"> Hypoxic burden can be defined as a value reflecting the area under the curve on the oxygen saturation curve during desaturation episodes. This value considers frequency, length, and depth of the respiratory-related oxygen desaturation. The role of hypoxic burden related to OSA in the occurrence of CV complications was studied by Azarbarzin et al in two different large cohorts: the Osteoporotic Fractures in Men Study (MrOS) and the SHHS. The researchers were able to show that OSA severity quantified as respiratory event-related hypoxic burden was independently associated with CVD mortality. This association persisted after adjusting for a large number of potential confounders and possible mediators, including prevalent CVD as well as AHI, T90%, and sleep duration. In contrast, CVD mortality was not associated with AHI when it was assessed as an independent variable. In this study, T90% was significantly associated with CVD mortality in the SHHS cohort (N=5111) but not in the MrOS cohort (N=2743), while ODI was associated with CVD mortality in the MrOS but not the SHHS cohort.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0063" ref-type="bibr">63</xref></citation_analysis><citation_analysis attribute="neither"> These data suggest that CVD mortality is strongly associated with a quantitative measure of hypoxic burden caused by respiratory disturbance, and that this measurement significantly and more consistently predicts CV outcomes compared to less precise OSA impact measurements such as respiratory event frequency (AHI), overall hypoxemia (T90%), or desaturation frequency (ODI) during sleep.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0063" ref-type="bibr">63</xref></citation_analysis></p>
        <p><citation_analysis attribute="positive">Other oxygen-related metrics have also been proposed. Kainulainen et al have proposed using “desaturation severity”, defined as the sum of the area under the curve of all desaturation events, normalized to TST, and “obstruction severity”, defined as the multiplication of the apnea duration by the desaturation area under the curve (</citation_analysis><citation_analysis attribute="positive"><xref rid="f0002" ref-type="fig">Figure 2</xref></citation_analysis><citation_analysis attribute="neither">). In their retrospective study, they showed that these indicators have a better correlation with excessive daytime sleepiness (EDS) compared to AHI and ODI.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0064" ref-type="bibr">64</xref></citation_analysis><citation_analysis attribute="positive"><fig position="float" id="f0002" fig-type="figure"><label>Figure 2</label><caption><p><citation_analysis attribute="neither">Calculation of the “obstruction severity” and “desaturation severity” metrics as proposed by Kainulainen et al</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0042" ref-type="bibr">42</xref></citation_analysis><citation_analysis attribute="neither">.</citation_analysis></p></caption><graphic xlink:href="NSS-14-1457-g0002" content-type="print-only" position="float"/></fig></citation_analysis></p>
        <p><citation_analysis attribute="positive">Kulkas et al reported that “obstruction severity” and “desaturation severity”, calculated as shown below, vary between the AHI severity categories. Interestingly, AHI was better correlated to apnea duration than to the number of events. The area under the curve of the desaturation events is part of the obstruction severity parameter (</citation_analysis><citation_analysis attribute="positive"><xref rid="f0002" ref-type="fig">Figure 2</xref></citation_analysis><citation_analysis attribute="positive">). Thus, both the duration and morphology of apnea, hypopnea, and desaturation events are included in the obstruction severity parameter.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0065" ref-type="bibr">65</xref></citation_analysis></p>
        <p><citation_analysis attribute="neither">In a retrospective study (N=1068), Muraja-Murro et al compared these indices in cohorts of alive and dead OSA patients, matched according to AHI, age, BMI, smoking habits, and follow-up time. Based on a multivariate logistic regression analysis, the authors found that higher “obstruction severity index” was statistically significantly associated with mortality in the severe OSA category.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0066" ref-type="bibr">66</xref></citation_analysis></p>
      </sec>
      <sec id="s0002-s2005">
        <title>How to Improve OSA-Related Hypoxemia Measurement in Clinical Practice?</title>
        <p><citation_analysis attribute="positive">As assessed by Azarbarzin et al,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0063" ref-type="bibr">63</xref></citation_analysis><citation_analysis attribute="positive"> one challenge of some commonly used metrics is that they depend on arbitrary absolute thresholds (eg, desaturation below 90% or 80%) which may not apply across populations. Metrics such as T90% are also used to measure the impact of the individual apneas and hypopneas as it can reflect underlying lung disease or a hypoventilation disorder, and thus are less specific markers of OSA-related hypoxic stress compared with the hypoxic burden measurement. T90% also does not provide direct information on the targets for OSA treatment (eg, CPAP), which mostly address episodic UA obstruction and the ensuing hypoxemia. In contrast, the hypoxic burden index quantifies a target for CPAP, and may possibly better identify individuals who will respond to CPAP than when using AHI or T90%. Hypoxic burden is not yet used in clinical practice, but one can imagine implementing an automated analysis of this index on top of manual scoring of PSG or HSAT recordings.</citation_analysis></p>
      </sec>
    </sec>
    <sec id="s0003">
      <title>Discussion</title>
      <p><citation_analysis attribute="positive">Obstructive apneas and hypopneas induce several pathophysiological modifications (eg, IH, arousals, respiratory effort, heart rate variability), provoking daytime and/or nighttime symptoms but also increasing cardiometabolic risk. PSG can capture most of these disturbances, but they are not well translated when expressing OSA severity through approximates such as AHI or T90%. The different phenotypes that have been documented in the OSA spectrum show the complexity of the disorder. Moreover, by using imperfect metrics, three recent large RCTs (the RICCADSA trial, the SAVE trial, and the ISAAC trial) failed to show a reduction in CV events with CPAP therapy in patients with a past history of CVD,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0067" ref-type="bibr">67–69</xref></citation_analysis><citation_analysis attribute="neither"> and other limitations can also occur, such as the exclusion of patients suffering from EDS.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0070" ref-type="bibr">70</xref></citation_analysis></p>
      <p><citation_analysis attribute="positive">Several studies that have been based on OSA-related hypoxemic burden have shown that these parameters better identify the OSA-related physiologic insults leading to CVD.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0062" ref-type="bibr">62</xref></citation_analysis></p>
      <p><citation_analysis attribute="neither">To better capture the whole picture of OSA, Randerath et al have already proposed a 2-dimensional classification for OSA (BAVENO), which considers the presence/absence of EDS and the presence/absence of end-stage organ injury or comorbidities.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0071" ref-type="bibr">71</xref></citation_analysis><citation_analysis attribute="neither"> This classification, in parallel to the GOLD classification in COPD, has the advantage of being multicomponent and considers several characteristics of OSA syndrome to identify the more severe patients. A slightly modified BAVENO classification has been applied to a large dataset of patients from the ESADA cohort (14,499 patients), followed between 2 and 3 years after CPAP treatment.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0072" ref-type="bibr">72</xref></citation_analysis><citation_analysis attribute="positive"> The authors demonstrated a significant relationship between the defined categories (A to D, from less to more severe) and treatment impact, with symptoms and/or comorbidities improving the most in C and D categories with CPAP. Hypoxic load, assessed by T90% and ODI, was not different in category C (no EDS, presence of end-stage organ injury or comorbidities) and B (EDS, absence of end-stage organ injury or comorbidities (or well-controlled)). Adding a quantitative metric of hypoxic burden could help to focus attention on patients susceptible to future risk, according to data from Azarbazin et al, highlighting a higher CV mortality in MrOS and SHHS cohorts for the Q4 and Q5 quintiles of hypoxic burden, respectively, between 53% and 88% min/hour or &gt;88% min/hour.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0063" ref-type="bibr">63</xref></citation_analysis></p>
      <p><citation_analysis attribute="neither">Based on these insights, we can now imagine proposing a 3D model with 8 categories of patients exhibiting a continuum of severity. This could be tested in a large OSA population dataset to assess the impact of these changes to patient assessment and OSA management. The proposed model is illustrated in </citation_analysis><citation_analysis attribute="positive"><xref rid="f0003" ref-type="fig">Figure 3</xref></citation_analysis><citation_analysis attribute="neither">.</citation_analysis><citation_analysis attribute="positive"><fig position="float" id="f0003" fig-type="figure"><label>Figure 3</label><caption><p><citation_analysis attribute="neither">Proposed 3-dimensional model that aims to assess 8 categories of OSA severity, considering Symptoms (excessive daytime sleepiness, ESS &lt;11 or &gt;11), comorbidities (presence/absence of end-stage organ injury or comorbidities) and severity factors on PSG (hypoxic burden below or &gt;53% min/hour). The circle shows the 4 categories of highest severity. In this model, the equal distribution between each severity category has been chosen arbitrarily since the prevalence of each category is currently unknown.</citation_analysis></p></caption><graphic xlink:href="NSS-14-1457-g0003" content-type="print-only" position="float"/><attrib><bold>Abbreviations</bold>: OSA, obstructive sleep apnea; ESS, Epworth Sleepiness Score; P(S)G, poly(somno)graphy.</attrib></fig></citation_analysis></p>
      <p><citation_analysis attribute="positive">However, despite the potential interest in such a model, there are limitations associated with using these multidimensional models. For example, these models use arbitrarily continuous variables as categories that have been tested only on retrospective cohorts and still need to be trialed in large prospective OSA patient cohorts to assess their value for OSA treatment choice and impact. Also, BMI, age, OSA duration and sex do not appear in these models, despite their potential impact on the occurrence of comorbidities and on the category of comorbidities.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0073" ref-type="bibr">73</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0074" ref-type="bibr">74</xref></citation_analysis></p>
      <p><citation_analysis attribute="neither">Finally, if the model is too complex, which could be the case with the model presented above (8 categories), it may be difficult to use in clinical practice.</citation_analysis></p>
      <p><citation_analysis attribute="neither">At this time, research is still ongoing to explore new metrics that assess the CV insults induced by OSA. Recently, Azarbarzin et al showed that high OSA-related heart rate response (pulse-rate response) was associated with CV events and all-cause mortality in longitudinal follow-up of the SHHS cohort (mean FU 10.7 years).</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0075" ref-type="bibr">75</xref></citation_analysis><citation_analysis attribute="neither"> Heart rate response relies only on measurement of respiration and pulse oximetry, easy to obtain with HSAT. Another feature of this measurement is that the analysis can be automated.</citation_analysis></p>
      <p><citation_analysis attribute="neither">Pulse wave amplitude (PWA) drops are another avenue that is being explored to obtain an overall assessment of sympathetic activation (autonomic vasoconstriction) during the night. Indeed, PWA drops can be easily detected by photoplethysmography and an automated detection algorithm has been recently published.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0076" ref-type="bibr">76</xref></citation_analysis><citation_analysis attribute="positive"> The clinical implications of this are as yet unknown, but it offers the advantage of being assessed by simplified, unobtrusive sensors. The clinical usefulness of PWA should be further studied.</citation_analysis></p>
    </sec>
    <sec id="s0004">
      <title>Conclusion</title>
      <p><citation_analysis attribute="positive">Commonly used PSG indices, such as AHI, ODI, and T90% are poor markers of CV insults induced by OSA. Hypoxic burden index differs in terms of its quantitative features, resulting in better assessment of CV outcomes when tested retrospectively on large OSA patient cohorts. However, prospective studies are yet lacking. Other markers of OSA-induced CV stress are also being developed, but data are yet limited. A multidimensional model, the BAVENO classification, has been developed to identify the more severe patients who will derive the most benefit from CPAP. However, while taking symptoms and comorbidities into account, no PSG parameter is included in the classification. Hypoxic burden could be added to the model to improve OSA patient classification to focus on the most symptomatic and also those patients with greatest future CV risk.</citation_analysis></p>
    </sec>
  </body>
  <back>
    <ack>
      <title>Acknowledgments</title>
      <p><citation_analysis attribute="neither">The authors would like to acknowledge the contribution of a medical writer, Sandy Field, PhD, for English language editing and formatting of this manuscript.</citation_analysis></p>
    </ack>
    <sec sec-type="COI-statement" id="s0005">
      <title>Disclosure</title>
      <p><citation_analysis attribute="neither">The authors declare no conflicts of interest in this work.</citation_analysis></p>
    </sec>
    <ref-list>
      <title>References</title>
      <ref id="cit0001">
        <label>1.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Heinzer</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Vat</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Marques-Vidal</surname>
<given-names>P</given-names></string-name>, et al. <article-title>Prevalence of sleep-disordered breathing in the general population: the HypnoLaus study</article-title>. <source><italic toggle="yes">Lancet Respir Med</italic></source>. <year>2015</year>;<volume>3</volume>(<issue>4</issue>):<fpage>310</fpage>–<lpage>318</lpage>. doi:<pub-id pub-id-type="doi">10.1016/S2213-2600(15)00043-0</pub-id><pub-id pub-id-type="pmid">25682233</pub-id></mixed-citation>
      </ref>
      <ref id="cit0002">
        <label>2.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Marin</surname>
<given-names>JM</given-names></string-name>, <string-name><surname>Carrizo</surname>
<given-names>SJ</given-names></string-name>, <string-name><surname>Vicente</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Agusti</surname>
<given-names>AG</given-names></string-name>. <article-title>Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study</article-title>. <source><italic toggle="yes">Lancet</italic></source>. <year>2005</year>;<volume>365</volume>(<issue>9464</issue>):<fpage>1046</fpage>–<lpage>1053</lpage>. doi:<pub-id pub-id-type="doi">10.1016/S0140-6736(05)71141-7</pub-id><pub-id pub-id-type="pmid">15781100</pub-id></mixed-citation>
      </ref>
      <ref id="cit0003">
        <label>3.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Arzt</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Oldenburg</surname>
<given-names>O</given-names></string-name>, <string-name><surname>Graml</surname>
<given-names>A</given-names></string-name>, et al. <article-title>Phenotyping of Sleep-Disordered Breathing in Patients With Chronic Heart Failure With Reduced Ejection Fraction—the SchlaHF Registry</article-title>. <source><italic toggle="yes">J Am Heart Assoc</italic></source>. <year>2017</year>;<volume>6</volume>(<issue>12</issue>):<fpage>e005899</fpage>. doi:<pub-id pub-id-type="doi">10.1161/JAHA.116.005899</pub-id><pub-id pub-id-type="pmid">29187390</pub-id></mixed-citation>
      </ref>
      <ref id="cit0004">
        <label>4.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Mehra</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Stone</surname>
<given-names>KL</given-names></string-name>, <string-name><surname>Varosy</surname>
<given-names>PD</given-names></string-name>, et al. <article-title>Nocturnal Arrhythmias across a spectrum of obstructive and central sleep-disordered breathing in older men: outcomes of sleep disorders in older men (MrOS sleep) study</article-title>. <source><italic toggle="yes">Arch Intern Med</italic></source>. <year>2009</year>;<volume>169</volume>(<issue>12</issue>):<fpage>1147</fpage>–<lpage>1155</lpage>. doi:<pub-id pub-id-type="doi">10.1001/archinternmed.2009.138</pub-id><pub-id pub-id-type="pmid">19546416</pub-id></mixed-citation>
      </ref>
      <ref id="cit0005">
        <label>5.</label>
        <mixed-citation publication-type="journal"><string-name><surname>McNicholas</surname>
<given-names>WT</given-names></string-name>, <string-name><surname>Bonsignore</surname>
<given-names>MR</given-names></string-name>. <article-title>Bonsignore MR and the Management Committee of EU COST ACTION B26. Sleep apnoea as an independent risk factor for cardiovascular disease: current evidence, basic mechanisms and research priorities</article-title>. <source><italic toggle="yes">European Respiratory Journal</italic></source>. <year>2006</year>;<volume>29</volume>(<issue>1</issue>):<fpage>156</fpage>–<lpage>178</lpage>. doi:<pub-id pub-id-type="doi">10.1183/09031936.00027406</pub-id></mixed-citation>
      </ref>
      <ref id="cit0006">
        <label>6.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Partinen</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Guilleminault</surname>
<given-names>C</given-names></string-name>. <article-title>Daytime Sleepiness and Vascular Morbidity at Seven-Year Follow-up in Obstructive Sleep Apnea Patients</article-title>. <source><italic toggle="yes">Chest</italic></source>. <year>1990</year>;<volume>97</volume>(<issue>1</issue>):<fpage>27</fpage>–<lpage>32</lpage>. doi:<pub-id pub-id-type="doi">10.1378/chest.97.1.27</pub-id><pub-id pub-id-type="pmid">2295260</pub-id></mixed-citation>
      </ref>
      <ref id="cit0007">
        <label>7.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Tamura</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Kawano</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Watanabe</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Kadota</surname>
<given-names>J</given-names></string-name>. <article-title>Relationship between the severity of obstructive sleep apnea and impaired glucose metabolism in patients with obstructive sleep apnea</article-title>. <source><italic toggle="yes">Respir Med</italic></source>. <year>2008</year>;<volume>102</volume>:<fpage>1412</fpage>–<lpage>1416</lpage>.<pub-id pub-id-type="pmid">18606532</pub-id></mixed-citation>
      </ref>
      <ref id="cit0008">
        <label>8.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Lam</surname>
<given-names>JCM</given-names></string-name>, <string-name><surname>Lui</surname>
<given-names>MMS</given-names></string-name>, <string-name><surname>Ip</surname>
<given-names>MSM</given-names></string-name>. <article-title>Diabetes and metabolic aspects of OSA</article-title>. <source><italic toggle="yes">Eur Respi Monogr</italic></source>. <year>2010</year>;<volume>2</volume>:<fpage>189</fpage>–<lpage>215</lpage>.</mixed-citation>
      </ref>
      <ref id="cit0009">
        <label>9.</label>
        <mixed-citation publication-type="book"><collab>American Academy of Sleep Medicine</collab>. <source><italic toggle="yes">The International Classification of Sleep Disorders</italic></source>. <edition>3rd</edition> ed. <publisher-loc>Darien, IL, USA</publisher-loc>: <publisher-name>American Academy of Sleep Medicine</publisher-name>; <year>2014</year>.</mixed-citation>
      </ref>
      <ref id="cit0010">
        <label>10.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Kushida</surname>
<given-names>CA</given-names></string-name>, <string-name><surname>Littner</surname>
<given-names>MR</given-names></string-name>, <string-name><surname>Morgenthaler</surname>
<given-names>T</given-names></string-name>, et al. <article-title>Practice Parameters for the indications for polysomnography and related procedures: an update for 2005</article-title>. <source><italic toggle="yes">Sleep</italic></source>. <year>2005</year>;<volume>28</volume>(<issue>4</issue>):<fpage>499</fpage>–<lpage>521</lpage>. doi:<pub-id pub-id-type="doi">10.1093/sleep/28.4.499</pub-id><pub-id pub-id-type="pmid">16171294</pub-id></mixed-citation>
      </ref>
      <ref id="cit0011">
        <label>11.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Collop</surname>
<given-names>NA</given-names></string-name>, <string-name><surname>Anderson</surname>
<given-names>WM</given-names></string-name>, <string-name><surname>Boehlecke</surname>
<given-names>B</given-names></string-name>, et al. <article-title>Clinical guidelines for the use of unattended portable monitors in the diagnosis of obstructive sleep apnea in adult patients. Portable Monitoring Task Force of the American Academy of Sleep Medicine</article-title>. <source><italic toggle="yes">J Clin Sleep Med</italic></source>. <year>2007</year>;<volume>3</volume>(<issue>7</issue>):<fpage>737</fpage>–<lpage>747</lpage>.<pub-id pub-id-type="pmid">18198809</pub-id></mixed-citation>
      </ref>
      <ref id="cit0012">
        <label>12.</label>
        <mixed-citation publication-type="journal"><string-name><surname>O’Mahony</surname>
<given-names>AM</given-names></string-name>, <string-name><surname>Garvey</surname>
<given-names>JF</given-names></string-name>, <string-name><surname>McNicholas</surname>
<given-names>WT</given-names></string-name>. <article-title>Technologic advances in the assessment and management of obstructive sleep apnoea beyond the apnoea-hypopnoea index: a narrative review</article-title>. <source><italic toggle="yes">J Thorac Dis</italic></source>. <year>2020</year>;<volume>12</volume>(<issue>9</issue>):<fpage>5020</fpage>–<lpage>5038</lpage>. doi:<pub-id pub-id-type="doi">10.21037/jtd-sleep-2020-003</pub-id><pub-id pub-id-type="pmid">33145074</pub-id></mixed-citation>
      </ref>
      <ref id="cit0013">
        <label>13.</label>
        <mixed-citation publication-type="book"><string-name><surname>Iber</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Ancoli-Israel</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Chesson</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Quan</surname>
<given-names>SF</given-names></string-name>. <source><italic toggle="yes">The AASM Manual for the Scoring of Sleep and Associated Events: Rules, Terminology and Technical Specifications</italic></source>. <publisher-loc>Westchester, IL</publisher-loc>: <publisher-name>American Academy of Sleep Medicine</publisher-name>; <year>2007</year>.</mixed-citation>
      </ref>
      <ref id="cit0014">
        <label>14.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Peppard</surname>
<given-names>PE</given-names></string-name>, <string-name><surname>Young</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Palta</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Skatrud</surname>
<given-names>J</given-names></string-name>. <article-title>Prospective study of the association between sleep-disordered breathing and hypertension</article-title>. <source><italic toggle="yes">N Engl J Med</italic></source>. <year>2000</year>;<volume>342</volume>(<issue>19</issue>):<fpage>1378</fpage>–<lpage>1384</lpage>. doi:<pub-id pub-id-type="doi">10.1056/NEJM200005113421901</pub-id><pub-id pub-id-type="pmid">10805822</pub-id></mixed-citation>
      </ref>
      <ref id="cit0015">
        <label>15.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Kendzerska</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Mollayeva</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Gershon</surname>
<given-names>AS</given-names></string-name>, <string-name><surname>Leung</surname>
<given-names>RS</given-names></string-name>, <string-name><surname>Hawker</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Tomlinson</surname>
<given-names>G</given-names></string-name>. <article-title>Untreated obstructive sleep apnea and the risk for serious long-term adverse outcomes: a systematic review</article-title>. <source><italic toggle="yes">Sleep Med Rev</italic></source>. <year>2014</year>;<volume>18</volume>(<issue>1</issue>):<fpage>49</fpage>–<lpage>59</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.smrv.2013.01.003</pub-id><pub-id pub-id-type="pmid">23642349</pub-id></mixed-citation>
      </ref>
      <ref id="cit0016">
        <label>16.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Pevernagie</surname>
<given-names>DA</given-names></string-name>, <string-name><surname>Gnidovec‐Strazisar</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Grote</surname>
<given-names>L</given-names></string-name>, et al. <article-title>On the rise and fall of the apnea−hypopnea index: a historical review and critical appraisal</article-title>. <source><italic toggle="yes">J Sleep Res</italic></source>. <year>2020</year>;<volume>29</volume>(<issue>4</issue>):<fpage>e13066</fpage>. doi:<pub-id pub-id-type="doi">10.1111/jsr.13066</pub-id><pub-id pub-id-type="pmid">32406974</pub-id></mixed-citation>
      </ref>
      <ref id="cit0017">
        <label>17.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Tkacova</surname>
<given-names>R</given-names></string-name>, <string-name><surname>McNicholas</surname>
<given-names>WT</given-names></string-name>, <string-name><surname>Javorsky</surname>
<given-names>M</given-names></string-name>, et al. <article-title>European Sleep Apnoea Database study collaborators. Nocturnal intermittent hypoxia predicts prevalent hypertension in the European Sleep Apnoea Database cohort study</article-title>. <source><italic toggle="yes">Eur Respir J</italic></source>. <year>2014</year>;<volume>44</volume>(<issue>4</issue>):<fpage>931</fpage>–<lpage>941</lpage>. doi:<pub-id pub-id-type="doi">10.1183/09031936.00225113</pub-id><pub-id pub-id-type="pmid">25102963</pub-id></mixed-citation>
      </ref>
      <ref id="cit0018">
        <label>18.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Zinchuk</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Yaggi</surname>
<given-names>HK</given-names></string-name>. <article-title>Phenotypic Subtypes of OSA: a Challenge and Opportunity for Precision Medicine</article-title>. <source><italic toggle="yes">Chest</italic></source>. <year>2020</year>;<volume>157</volume>(<issue>2</issue>):<fpage>403</fpage>–<lpage>420</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.chest.2019.09.002</pub-id><pub-id pub-id-type="pmid">31539538</pub-id></mixed-citation>
      </ref>
      <ref id="cit0019">
        <label>19.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Bonsignore</surname>
<given-names>MR</given-names></string-name>, <string-name><surname>Suarez Giron</surname>
<given-names>MC</given-names></string-name>, <string-name><surname>Marrone</surname>
<given-names>O</given-names></string-name>, <string-name><surname>Castrogiovanni</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Montserrat</surname>
<given-names>JM</given-names></string-name>. <article-title>Personalised medicine in sleep respiratory disorders: focus on obstructive sleep apnoea diagnosis and treatment</article-title>. <source><italic toggle="yes">Eur Respir Rev</italic></source>. <year>2017</year>;<volume>26</volume>(<issue>146</issue>):<fpage>170069</fpage>. doi:<pub-id pub-id-type="doi">10.1183/16000617.0069-2017</pub-id><pub-id pub-id-type="pmid">29070581</pub-id></mixed-citation>
      </ref>
      <ref id="cit0020">
        <label>20.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Bailly</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Destors</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Grillet</surname>
<given-names>Y</given-names></string-name>, et al. <article-title>Obstructive Sleep Apnea: a Cluster Analysis at Time of Diagnosis</article-title>. <source><italic toggle="yes">PLoS One</italic></source>. <year>2016</year>;<volume>11</volume>:<fpage>e0157318</fpage>.<pub-id pub-id-type="pmid">27314230</pub-id></mixed-citation>
      </ref>
      <ref id="cit0021">
        <label>21.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Martinez-Garcia</surname>
<given-names>M-A</given-names></string-name>, <string-name><surname>Campos-Rodriguez</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Catalan-Serra</surname>
<given-names>P</given-names></string-name>, et al. <article-title>Cardiovascular mortality in obstructive sleep apnea in the elderly: role of long-term continuous positive airway pressure treatment: a prospective observational study</article-title>. <source><italic toggle="yes">Am J Respir Crit Care Med</italic></source>. <year>2012</year>;<volume>186</volume>(<issue>9</issue>):<fpage>909</fpage>–<lpage>916</lpage>. doi:<pub-id pub-id-type="doi">10.1164/rccm.201203-0448OC</pub-id><pub-id pub-id-type="pmid">22983957</pub-id></mixed-citation>
      </ref>
      <ref id="cit0022">
        <label>22.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Stone</surname>
<given-names>KL</given-names></string-name>, <string-name><surname>Blackwell</surname>
<given-names>TL</given-names></string-name>, <string-name><surname>Ancoli-Israel</surname>
<given-names>S</given-names></string-name>, et al. <article-title>Sleep disordered breathing and risk of stroke in older community-dwelling men</article-title>. <source><italic toggle="yes">Sleep</italic></source>. <year>2016</year>;<volume>39</volume>(<issue>3</issue>):<fpage>531</fpage>–<lpage>540</lpage>. doi:<pub-id pub-id-type="doi">10.5665/sleep.5520</pub-id><pub-id pub-id-type="pmid">26943468</pub-id></mixed-citation>
      </ref>
      <ref id="cit0023">
        <label>23.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Gagnadoux</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Le Vaillant</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Paris</surname>
<given-names>A</given-names></string-name>, et al. <article-title>Relationship between OSA clinical phenotypes and CPAP treatment outcomes</article-title>. <source><italic toggle="yes">Chest</italic></source>. <year>2016</year>;<volume>149</volume>(<issue>1</issue>):<fpage>288</fpage>–<lpage>290</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.chest.2015.09.032</pub-id><pub-id pub-id-type="pmid">26757296</pub-id></mixed-citation>
      </ref>
      <ref id="cit0024">
        <label>24.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Mazzotti</surname>
<given-names>DR</given-names></string-name>, <string-name><surname>Keenan</surname>
<given-names>BT</given-names></string-name>, <string-name><surname>Lim</surname>
<given-names>DC</given-names></string-name>, <string-name><surname>Gottlieb</surname>
<given-names>DJ</given-names></string-name>, <string-name><surname>Kim</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Pack</surname>
<given-names>AI</given-names></string-name>. <article-title>Symptom Subtypes of Obstructive Sleep Apnea Predict Incidence of Cardiovascular Outcomes</article-title>. <source><italic toggle="yes">Am J Respir Crit Care Med</italic></source>. <year>2019</year>;<volume>200</volume>(<issue>4</issue>):<fpage>493</fpage>–<lpage>506</lpage>. doi:<pub-id pub-id-type="doi">10.1164/rccm.201808-1509OC</pub-id><pub-id pub-id-type="pmid">30764637</pub-id></mixed-citation>
      </ref>
      <ref id="cit0025">
        <label>25.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Subramani</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Singh</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Wong</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Kushida</surname>
<given-names>CA</given-names></string-name>, <string-name><surname>Malhotra</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Chung</surname>
<given-names>F</given-names></string-name>. <article-title>Understanding Phenotypes of Obstructive Sleep Apnea: applications in Anesthesia, Surgery, and Perioperative Medicine</article-title>. <source><italic toggle="yes">Anesth Analg</italic></source>. <year>2017</year>;<volume>124</volume>(<issue>1</issue>):<fpage>179</fpage>–<lpage>191</lpage>. doi:<pub-id pub-id-type="doi">10.1213/ANE.0000000000001546</pub-id><pub-id pub-id-type="pmid">27861433</pub-id></mixed-citation>
      </ref>
      <ref id="cit0026">
        <label>26.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Cao</surname>
<given-names>W</given-names></string-name>, <string-name><surname>Luo</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Xiao</surname>
<given-names>Y</given-names></string-name>. <article-title>A review of current tools used for evaluating the severity of obstructive sleep apnea</article-title>. <source><italic toggle="yes">Nat Sci Sleep</italic></source>. <year>2020</year>;<volume>12</volume>:<fpage>1023</fpage>–<lpage>1031</lpage>. doi:<pub-id pub-id-type="doi">10.2147/NSS.S275252</pub-id><pub-id pub-id-type="pmid">33239929</pub-id></mixed-citation>
      </ref>
      <ref id="cit0027">
        <label>27.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Hirotsu</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Haba-Rubio</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Andries</surname>
<given-names>D</given-names></string-name>, et al. <article-title>Effect of Three Hypopnea Scoring Criteria on OSA Prevalence and Associated Comorbidities in the General Population</article-title>. <source><italic toggle="yes">J Clin Sleep Med</italic></source>. <year>2019</year>;<volume>15</volume>(<issue>2</issue>):<fpage>183</fpage>–<lpage>194</lpage>. doi:<pub-id pub-id-type="doi">10.5664/jcsm.7612</pub-id><pub-id pub-id-type="pmid">30736872</pub-id></mixed-citation>
      </ref>
      <ref id="cit0028">
        <label>28.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Lipford</surname>
<given-names>MC</given-names></string-name>, <string-name><surname>Wahner-Roedler</surname>
<given-names>DL</given-names></string-name>, <string-name><surname>Welsh</surname>
<given-names>GA</given-names></string-name>, <string-name><surname>Mandrekar</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Thapa</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Olson</surname>
<given-names>EJ</given-names></string-name>. <article-title>Correlation of the Epworth Sleepiness Scale and Sleep-Disordered Breathing in Men and Women</article-title>. <source><italic toggle="yes">J Clin Sleep Med</italic></source>. <year>2019</year>;<volume>15</volume>(<issue>1</issue>):<fpage>33</fpage>–<lpage>38</lpage>. doi:<pub-id pub-id-type="doi">10.5664/jcsm.7564</pub-id><pub-id pub-id-type="pmid">30621827</pub-id></mixed-citation>
      </ref>
      <ref id="cit0029">
        <label>29.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Bouloukaki</surname>
<given-names>I</given-names></string-name>, <string-name><surname>Grote</surname>
<given-names>L</given-names></string-name>, <string-name><surname>McNicholas</surname>
<given-names>WT</given-names></string-name>, et al. <article-title>European Sleep Apnoea Database Network. Mild obstructive sleep apnea increases hypertension risk, challenging traditional severity classification</article-title>. <source><italic toggle="yes">J Clin Sleep Med</italic></source>. <year>2020</year>;<volume>16</volume>(<issue>6</issue>):<fpage>889</fpage>–<lpage>898</lpage>. doi:<pub-id pub-id-type="doi">10.5664/jcsm.8354</pub-id><pub-id pub-id-type="pmid">32043960</pub-id></mixed-citation>
      </ref>
      <ref id="cit0030">
        <label>30.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Lechat</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Naik</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Reynolds</surname>
<given-names>A</given-names></string-name>, et al. <article-title>Multinight Prevalence, Variability, and Diagnostic Misclassification of Obstructive Sleep Apnea</article-title>. <source><italic toggle="yes">Am J Respir Crit Care Med</italic></source>. <year>2022</year>;<volume>205</volume>(<issue>5</issue>):<fpage>563</fpage>–<lpage>569</lpage>. doi:<pub-id pub-id-type="doi">10.1164/rccm.202107-1761OC</pub-id><pub-id pub-id-type="pmid">34904935</pub-id></mixed-citation>
      </ref>
      <ref id="cit0031">
        <label>31.</label>
        <mixed-citation publication-type="journal"><string-name><surname>André</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Andreozzi</surname>
<given-names>F</given-names></string-name>, Van <string-name><surname>Overstraeten</surname>
<given-names>C</given-names></string-name>, et al. <article-title>Cardiometabolic comorbidities in obstructive sleep apnea patients are related to disease severity, nocturnal hypoxemia, and decreased sleep quality</article-title>. <source><italic toggle="yes">Respir Res</italic></source>. <year>2020</year>;<volume>21</volume>(<issue>1</issue>):<fpage>35</fpage>. doi:<pub-id pub-id-type="doi">10.1186/s12931-020-1284-7</pub-id><pub-id pub-id-type="pmid">31996224</pub-id></mixed-citation>
      </ref>
      <ref id="cit0032">
        <label>32.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Wu</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Zhan</surname>
<given-names>X</given-names></string-name>, <string-name><surname>Zhao</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Wei</surname>
<given-names>Y</given-names></string-name>. <article-title>Mean apnea–hypopnea duration (but not apnea–hypopnea index) is associated with worse hypertension in patients with obstructive sleep apnea</article-title>. <source><italic toggle="yes">Medicine</italic></source>. <year>2016</year>;<volume>95</volume>(<issue>48</issue>):<fpage>e5493</fpage>. doi:<pub-id pub-id-type="doi">10.1097/MD.0000000000005493</pub-id><pub-id pub-id-type="pmid">27902610</pub-id></mixed-citation>
      </ref>
      <ref id="cit0033">
        <label>33.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Mokhlesi</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Finn</surname>
<given-names>LA</given-names></string-name>, <string-name><surname>Hagen</surname>
<given-names>EW</given-names></string-name>, et al. <article-title>Obstructive sleep apnea during REM sleep and hypertension. results of the Wisconsin Sleep Cohort</article-title>. <source><italic toggle="yes">Am J Respir Crit Care Med</italic></source>. <year>2014</year>;<volume>190</volume>(<issue>10</issue>):<fpage>1158</fpage>–<lpage>1167</lpage>. doi:<pub-id pub-id-type="doi">10.1164/rccm.201406-1136OC</pub-id><pub-id pub-id-type="pmid">25295854</pub-id></mixed-citation>
      </ref>
      <ref id="cit0034">
        <label>34.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Oldenburg</surname>
<given-names>O</given-names></string-name>, <string-name><surname>Wellmann</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Buchholz</surname>
<given-names>A</given-names></string-name>, et al. <article-title>Nocturnal hypoxaemia is associated with increased mortality in stable heart failure patients</article-title>. <source><italic toggle="yes">Eur Heart J</italic></source>. <year>2016</year>;<volume>37</volume>(<issue>21</issue>):<fpage>1695</fpage>–<lpage>1703</lpage>. doi:<pub-id pub-id-type="doi">10.1093/eurheartj/ehv624</pub-id><pub-id pub-id-type="pmid">26612581</pub-id></mixed-citation>
      </ref>
      <ref id="cit0035">
        <label>35.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Smagula</surname>
<given-names>SF</given-names></string-name>, <string-name><surname>Stone</surname>
<given-names>KL</given-names></string-name>, <string-name><surname>Redline</surname>
<given-names>S</given-names></string-name>, et al. <article-title>Actigraphy- and Polysomnography-Measured Sleep Disturbances, Inflammation, and Mortality Among Older Men</article-title>. <source><italic toggle="yes">Psychosom Med</italic></source>. <year>2016</year>;<volume>78</volume>(<issue>6</issue>):<fpage>686</fpage>–<lpage>696</lpage>. doi:<pub-id pub-id-type="doi">10.1097/PSY.0000000000000312</pub-id><pub-id pub-id-type="pmid">26894325</pub-id></mixed-citation>
      </ref>
      <ref id="cit0036">
        <label>36.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Jung</surname>
<given-names>HH</given-names></string-name>, <string-name><surname>Lee</surname>
<given-names>JH</given-names></string-name>, <string-name><surname>Baek</surname>
<given-names>HJ</given-names></string-name>, <string-name><surname>Kim</surname>
<given-names>SJ</given-names></string-name>, <string-name><surname>Lee</surname>
<given-names>JJ</given-names></string-name>. <article-title>Nocturnal Hypoxemia and Periodic Limb Movement Predict Mortality in Patients on Maintenance Hemodialysis</article-title>. <source><italic toggle="yes">Clin J Am Soc Nephrol</italic></source>. <year>2010</year>;<volume>5</volume>(<issue>9</issue>):<fpage>1607</fpage>–<lpage>1613</lpage>. doi:<pub-id pub-id-type="doi">10.2215/CJN.08881209</pub-id><pub-id pub-id-type="pmid">20507958</pub-id></mixed-citation>
      </ref>
      <ref id="cit0037">
        <label>37.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Malhotra</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Ayappa</surname>
<given-names>I</given-names></string-name>, <string-name><surname>Ayas</surname>
<given-names>N</given-names></string-name>, et al. <article-title>Metrics of sleep apnea severity: beyond the apnea-hypopnea index</article-title>. <source><italic toggle="yes">Sleep</italic></source>. <year>2021</year>;<volume>44</volume>(<issue>7</issue>):<fpage>zsab030</fpage>. doi:<pub-id pub-id-type="doi">10.1093/sleep/zsab030</pub-id><pub-id pub-id-type="pmid">33693939</pub-id></mixed-citation>
      </ref>
      <ref id="cit0038">
        <label>38.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Ryan</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Nicholas</surname>
<given-names>WT</given-names></string-name>. <article-title>Intermittent hypoxia and activation of inflammatory molecular pathways in OSAS</article-title>. <source><italic toggle="yes">Archives of Physiology and Biochemistry</italic></source>. <year>2008</year>;<volume>114</volume>(<issue>4</issue>):<fpage>261</fpage>–<lpage>266</lpage>. doi:<pub-id pub-id-type="doi">10.1080/13813450802307337</pub-id><pub-id pub-id-type="pmid">18946786</pub-id></mixed-citation>
      </ref>
      <ref id="cit0039">
        <label>39.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Dewan</surname>
<given-names>NA</given-names></string-name>, <string-name><surname>Nieto</surname>
<given-names>FJ</given-names></string-name>, <string-name><surname>Somers</surname>
<given-names>VK</given-names></string-name>. <article-title>Intermittent hypoxemia and OSA: implications for comorbidities</article-title>. <source><italic toggle="yes">Chest</italic></source>. <year>2015</year>;<volume>147</volume>(<issue>1</issue>):<fpage>266</fpage>–<lpage>274</lpage>. doi:<pub-id pub-id-type="doi">10.1378/chest.14-0500</pub-id><pub-id pub-id-type="pmid">25560865</pub-id></mixed-citation>
      </ref>
      <ref id="cit0040">
        <label>40.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Prabhakar</surname>
<given-names>NR</given-names></string-name>, <string-name><surname>Semenza</surname>
<given-names>GL</given-names></string-name>. <article-title>Adaptive and maladaptive cardiorespiratory responses to continuous and intermittent hypoxia mediated by hypoxia-inducible factors 1 and 2</article-title>. <source><italic toggle="yes">Physiol Rev</italic></source>. <year>2012</year>;<volume>92</volume>(<issue>3</issue>):<fpage>967</fpage>–<lpage>1003</lpage>. doi:<pub-id pub-id-type="doi">10.1152/physrev.00030.2011</pub-id><pub-id pub-id-type="pmid">22811423</pub-id></mixed-citation>
      </ref>
      <ref id="cit0041">
        <label>41.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Adedayo</surname>
<given-names>AM</given-names></string-name>, <string-name><surname>Olafiranye</surname>
<given-names>O</given-names></string-name>, <string-name><surname>Smith</surname>
<given-names>D</given-names></string-name>, et al. <article-title>Obstructive sleep apnea and dyslipidemia: evidence and underlying mechanism</article-title>. <source><italic toggle="yes">Sleep and Breathing</italic></source>. <year>2014</year>;<volume>18</volume>(<issue>1</issue>):<fpage>13</fpage>–<lpage>18</lpage>. doi:<pub-id pub-id-type="doi">10.1007/s11325-012-0760-9</pub-id><pub-id pub-id-type="pmid">22903801</pub-id></mixed-citation>
      </ref>
      <ref id="cit0042">
        <label>42.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Barros</surname>
<given-names>D</given-names></string-name>, <string-name><surname>García-Río</surname>
<given-names>F</given-names></string-name>. <article-title>Obstructive sleep apnea and dyslipidemia: from animal models to clinical evidence</article-title>. <source><italic toggle="yes">Sleep</italic></source>. <year>2019</year>;<volume>42</volume>(<issue>3</issue>):<fpage>zsy236</fpage>. doi:<pub-id pub-id-type="doi">10.1093/sleep/zsy236</pub-id><pub-id pub-id-type="pmid">30476296</pub-id></mixed-citation>
      </ref>
      <ref id="cit0043">
        <label>43.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Wang</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Yan</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Song</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Ye</surname>
<given-names>X</given-names></string-name>, <string-name><surname>Liu</surname>
<given-names>SF</given-names></string-name>. <article-title>Chronic intermittent hypoxia down-regulates endothelial nitric oxide synthase expression by an NF-κB-dependent mechanism</article-title>. <source><italic toggle="yes">Sleep Med</italic></source>. <year>2013</year>;<volume>14</volume>(<issue>2</issue>):<fpage>165</fpage>–<lpage>171</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.sleep.2012.10.020</pub-id><pub-id pub-id-type="pmid">23266106</pub-id></mixed-citation>
      </ref>
      <ref id="cit0044">
        <label>44.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Belaidi</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Joyeux-Faure</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Ribuot</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Launois</surname>
<given-names>SH</given-names></string-name>, <string-name><surname>Levy</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Godin-Ribuot</surname>
<given-names>D</given-names></string-name>. <article-title>Major role for hypoxia inducible factor-1 and the endothelin system in promoting myocardial infarction and hypertension in an animal model of obstructive sleep apnea</article-title>. <source><italic toggle="yes">J Am Coll Cardiol</italic></source>. <year>2009</year>;<volume>53</volume>(<issue>15</issue>):<fpage>1309</fpage>–<lpage>1317</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.jacc.2008.12.050</pub-id><pub-id pub-id-type="pmid">19358946</pub-id></mixed-citation>
      </ref>
      <ref id="cit0045">
        <label>45.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Kohler</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Stradling</surname>
<given-names>JR</given-names></string-name>. <article-title>Mechanisms of vascular damage in obstructive sleep apnea</article-title>. <source><italic toggle="yes">Nat Rev Cardiol</italic></source>. <year>2010</year>;<volume>7</volume>(<issue>12</issue>):<fpage>677</fpage>–<lpage>685</lpage>. doi:<pub-id pub-id-type="doi">10.1038/nrcardio.2010.145</pub-id><pub-id pub-id-type="pmid">21079639</pub-id></mixed-citation>
      </ref>
      <ref id="cit0046">
        <label>46.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Apovian</surname>
<given-names>CM</given-names></string-name>, <string-name><surname>Bigornia</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Mott</surname>
<given-names>M</given-names></string-name>, et al. <article-title>Adipose macrophage infiltration is associated with insulin resistance and vascular endothelial dysfunction in obese subjects</article-title>. <source><italic toggle="yes">Arterioscler Thromb Vasc Biol</italic></source>. <year>2008</year>;<volume>28</volume>(<issue>9</issue>):<fpage>1654</fpage>–<lpage>1659</lpage>. doi:<pub-id pub-id-type="doi">10.1161/ATVBAHA.108.170316</pub-id><pub-id pub-id-type="pmid">18566296</pub-id></mixed-citation>
      </ref>
      <ref id="cit0047">
        <label>47.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Hotamisligil</surname>
<given-names>GS</given-names></string-name>. <article-title>Inflammation and metabolic disorders</article-title>. <source><italic toggle="yes">Nature</italic></source>. <year>2006</year>;<volume>444</volume>(<issue>7121</issue>):<fpage>860</fpage>–<lpage>867</lpage>. doi:<pub-id pub-id-type="doi">10.1038/nature05485</pub-id><pub-id pub-id-type="pmid">17167474</pub-id></mixed-citation>
      </ref>
      <ref id="cit0048">
        <label>48.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Alam</surname>
<given-names>I</given-names></string-name>, <string-name><surname>Lewis</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Stephens</surname>
<given-names>JW</given-names></string-name>, <string-name><surname>Baxter</surname>
<given-names>JN</given-names></string-name>. <article-title>Obesity, metabolic syndrome and sleep apnoea: all pro-inflammatory states</article-title>. <source><italic toggle="yes">Obes Rev</italic></source>. <year>2007</year>;<volume>8</volume>(<issue>2</issue>):<fpage>119</fpage>–<lpage>127</lpage>. doi:<pub-id pub-id-type="doi">10.1111/j.1467-789X.2006.00269.x</pub-id><pub-id pub-id-type="pmid">17300278</pub-id></mixed-citation>
      </ref>
      <ref id="cit0049">
        <label>49.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Hillman</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Singh</surname>
<given-names>B</given-names></string-name>, <string-name><surname>McArdle</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Eastwood</surname>
<given-names>P</given-names></string-name>. <article-title>Relationships between ventilatory impairment, sleep hypoventilation and type 2 respiratory failure</article-title>. <source><italic toggle="yes">Respirology</italic></source>. <year>2014</year>;<volume>19</volume>(<issue>8</issue>):<fpage>1106</fpage>–<lpage>1116</lpage>. doi:<pub-id pub-id-type="doi">10.1111/resp.12376</pub-id><pub-id pub-id-type="pmid">25219542</pub-id></mixed-citation>
      </ref>
      <ref id="cit0050">
        <label>50.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Borel</surname>
<given-names>J-C</given-names></string-name>, <string-name><surname>Roux-Lombard</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Tamisier</surname>
<given-names>R</given-names></string-name>, et al. <article-title>Endothelial Dysfunction and Specific Inflammation in Obesity Hypoventilation Syndrome</article-title>. <source><italic toggle="yes">PLoS One</italic></source>. <year>2009</year>;<volume>4</volume>(<issue>8</issue>):<fpage>e6733</fpage>. doi:<pub-id pub-id-type="doi">10.1371/journal.pone.0006733</pub-id><pub-id pub-id-type="pmid">19701463</pub-id></mixed-citation>
      </ref>
      <ref id="cit0051">
        <label>51.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Ryan</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Taylor</surname>
<given-names>CT</given-names></string-name>, <string-name><surname>McNicholas</surname>
<given-names>WT</given-names></string-name>. <article-title>Predictors of Elevated Nuclear Factor-κB–dependent Genes in Obstructive Sleep Apnea Syndrome</article-title>. <source><italic toggle="yes">Am J Respir Crit Care Med</italic></source>. <year>2006</year>;<volume>174</volume>(<issue>7</issue>):<fpage>824</fpage>–<lpage>830</lpage>. doi:<pub-id pub-id-type="doi">10.1164/rccm.200601-066OC</pub-id><pub-id pub-id-type="pmid">16840748</pub-id></mixed-citation>
      </ref>
      <ref id="cit0052">
        <label>52.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Somers</surname>
<given-names>VK</given-names></string-name>, <string-name><surname>Mark</surname>
<given-names>AL</given-names></string-name>, <string-name><surname>Zavala</surname>
<given-names>DC</given-names></string-name>, <string-name><surname>Abboud</surname>
<given-names>FM</given-names></string-name>. <article-title>Contrasting effects of hypoxia and hypercapnia on ventilation and sympathetic activity in humans</article-title>. <source><italic toggle="yes">J Appl Physiol</italic></source>. <year>1989</year>;<volume>67</volume>(<issue>5</issue>):<fpage>2101</fpage>–<lpage>2106</lpage>. doi:<pub-id pub-id-type="doi">10.1152/jappl.1989.67.5.2101</pub-id><pub-id pub-id-type="pmid">2513316</pub-id></mixed-citation>
      </ref>
      <ref id="cit0053">
        <label>53.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Narkiewicz</surname>
<given-names>K</given-names></string-name>, <string-name><surname>van de Borne</surname>
<given-names>PJH</given-names></string-name>, <string-name><surname>Pesek</surname>
<given-names>CA</given-names></string-name>, <string-name><surname>Dyken</surname>
<given-names>ME</given-names></string-name>, <string-name><surname>Montano</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Somers</surname>
<given-names>VK</given-names></string-name>. <article-title>Selective potentiation of peripheral chemoreflex sensitivity in obstructive sleep apnea</article-title>. <source><italic toggle="yes">Circulation</italic></source>. <year>1999</year>;<volume>99</volume>(<issue>9</issue>):<fpage>1183</fpage>–<lpage>1189</lpage>. doi:<pub-id pub-id-type="doi">10.1161/01.CIR.99.9.1183</pub-id><pub-id pub-id-type="pmid">10069786</pub-id></mixed-citation>
      </ref>
      <ref id="cit0054">
        <label>54.</label>
        <mixed-citation publication-type="journal"><string-name><surname>De Burgh Daly</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Scott</surname>
<given-names>MJ</given-names></string-name>. <article-title>An analysis of the primary cardiovascular reflex effects of stimulation of the carotid body chemoreceptors in the dog</article-title>. <source><italic toggle="yes">J Physiol</italic></source>. <year>1962</year>;<volume>162</volume>(<issue>3</issue>):<fpage>555</fpage>–<lpage>573</lpage>. doi:<pub-id pub-id-type="doi">10.1113/jphysiol.1962.sp006950</pub-id><pub-id pub-id-type="pmid">13884147</pub-id></mixed-citation>
      </ref>
      <ref id="cit0055">
        <label>55.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Daly</surname>
<given-names>MD</given-names></string-name>, <string-name><surname>Angell-James</surname>
<given-names>JE</given-names></string-name>, <string-name><surname>Elsner</surname>
<given-names>R</given-names></string-name>. <article-title>Role of carotid-body chemoreceptors and their reflex interactions in bradycardia and cardiac arrest</article-title>. <source><italic toggle="yes">Lancet</italic></source>. <year>1979</year>;<volume>313</volume>(<issue>8119</issue>):<fpage>764</fpage>–<lpage>767</lpage>. doi:<pub-id pub-id-type="doi">10.1016/S0140-6736(79)91218-2</pub-id></mixed-citation>
      </ref>
      <ref id="cit0056">
        <label>56.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Hohl</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Linz</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Böhm</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Linz</surname>
<given-names>D</given-names></string-name>. <article-title>Obstructive sleep apnea and atrial arrhythmogenesis</article-title>. <source><italic toggle="yes">Curr Cardiol Rev</italic></source>. <year>2014</year>;<volume>10</volume>(<issue>4</issue>):<fpage>362</fpage>–<lpage>368</lpage>. doi:<pub-id pub-id-type="doi">10.2174/1573403X1004140707125137</pub-id><pub-id pub-id-type="pmid">25004989</pub-id></mixed-citation>
      </ref>
      <ref id="cit0057">
        <label>57.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Sert Kuniyoshi</surname>
<given-names>FH</given-names></string-name>, <string-name><surname>Singh</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Gami</surname>
<given-names>AS</given-names></string-name>, et al. <article-title>Patients with obstructive sleep apnea exhibit impaired endothelial function after myocardial infarction</article-title>. <source><italic toggle="yes">Chest</italic></source>. <year>2011</year>;<volume>140</volume>(<issue>1</issue>):<fpage>62</fpage>–<lpage>67</lpage>. doi:<pub-id pub-id-type="doi">10.1378/chest.10-1722</pub-id><pub-id pub-id-type="pmid">21349927</pub-id></mixed-citation>
      </ref>
      <ref id="cit0058">
        <label>58.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Lavie</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Lavie</surname>
<given-names>P</given-names></string-name>. <article-title>Molecular mechanisms of cardiovascular disease in OSAHS: the oxidative stress link</article-title>. <source><italic toggle="yes">Eur Respir J</italic></source>. <year>2009</year>;<volume>33</volume>(<issue>6</issue>):<fpage>1467</fpage>–<lpage>1484</lpage>. doi:<pub-id pub-id-type="doi">10.1183/09031936.00086608</pub-id><pub-id pub-id-type="pmid">19483049</pub-id></mixed-citation>
      </ref>
      <ref id="cit0059">
        <label>59.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Lebkuchen</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Freitas</surname>
<given-names>LS</given-names></string-name>, <string-name><surname>Cardozo</surname>
<given-names>KHM</given-names></string-name>, <string-name><surname>Drager</surname>
<given-names>LF</given-names></string-name>. <article-title>Advances and challenges in pursuing biomarkers for obstructive sleep apnea: implications for the cardiovascular risk</article-title>. <source><italic toggle="yes">Trends Cardiovasc Med</italic></source>. <year>2021</year>;<volume>31</volume>(<issue>4</issue>):<fpage>242</fpage>–<lpage>249</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.tcm.2020.04.003</pub-id><pub-id pub-id-type="pmid">32413393</pub-id></mixed-citation>
      </ref>
      <ref id="cit0060">
        <label>60.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Fiedorczuk</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Stróżyński</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Olszewska</surname>
<given-names>E</given-names></string-name>. <article-title>Is the Oxidative Stress in Obstructive Sleep Apnea Associated with Cardiovascular Complications?—Systematic Review</article-title>. <source><italic toggle="yes">J Clin Med</italic></source>. <year>2020</year>;<volume>9</volume>(<issue>11</issue>):<fpage>3734</fpage>. doi:<pub-id pub-id-type="doi">10.3390/jcm9113734</pub-id></mixed-citation>
      </ref>
      <ref id="cit0061">
        <label>61.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Bikov</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Frent</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Pleava</surname>
<given-names>R</given-names></string-name>, et al. <article-title>The Burden of Associated Comorbidities in Patients with Obstructive Sleep Apnea—Regional Differences in Two Central–Eastern European Sleep Centers</article-title>. <source><italic toggle="yes">J Clin Med</italic></source>. <year>2020</year>;<volume>9</volume>(<issue>11</issue>):<fpage>3583</fpage>. doi:<pub-id pub-id-type="doi">10.3390/jcm9113583</pub-id></mixed-citation>
      </ref>
      <ref id="cit0062">
        <label>62.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Terril</surname>
<given-names>P</given-names></string-name>. <article-title>A review of approaches for analysing obstructive sleep apnoea-related patterns in pulse oximetry data</article-title>. <source><italic toggle="yes">Respirology</italic></source>. <year>2020</year>;<volume>25</volume>(<issue>5</issue>):<fpage>475</fpage>–<lpage>485</lpage>. doi:<pub-id pub-id-type="doi">10.1111/resp.13635</pub-id><pub-id pub-id-type="pmid">31246376</pub-id></mixed-citation>
      </ref>
      <ref id="cit0063">
        <label>63.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Azarbarzin</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Sands</surname>
<given-names>SA</given-names></string-name>, <string-name><surname>Stone</surname>
<given-names>KL</given-names></string-name>, et al. <article-title>The hypoxic burden of sleep apnoea predicts cardiovascular disease-related mortality: the Osteoporotic Fractures in Men Study and the Sleep Heart Health Study</article-title>. <source><italic toggle="yes">Eur Heart J</italic></source>. <year>2019</year>;<volume>40</volume>(<issue>14</issue>):<fpage>1149</fpage>–<lpage>1157</lpage>. doi:<pub-id pub-id-type="doi">10.1093/eurheartj/ehy624</pub-id><pub-id pub-id-type="pmid">30376054</pub-id></mixed-citation>
      </ref>
      <ref id="cit0064">
        <label>64.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Kainulainen</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Töyräs</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Oksenberg</surname>
<given-names>A</given-names></string-name>. <article-title>Severity of Desaturations Reflects OSA-Related Daytime Sleepiness Better Than AHI</article-title>. <source><italic toggle="yes">J Clin Sleep Med</italic></source>. <year>2019</year>;<volume>15</volume>(<issue>8</issue>):<fpage>1135</fpage>–<lpage>1142</lpage>. doi:<pub-id pub-id-type="doi">10.5664/jcsm.7806</pub-id><pub-id pub-id-type="pmid">31482835</pub-id></mixed-citation>
      </ref>
      <ref id="cit0065">
        <label>65.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Kulkas</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Tiihonen</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Julkunen</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Mervaala</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Töyräs</surname>
<given-names>J</given-names></string-name>. <article-title>Novel parameters indicate significant differences in severity of obstructive sleep apnea with patients having similar apnea–hypopnea index</article-title>. <source><italic toggle="yes">Med Biol Eng Comput</italic></source>. <year>2013</year>;<volume>51</volume>:<fpage>697</fpage>–<lpage>708</lpage>.<pub-id pub-id-type="pmid">23417543</pub-id></mixed-citation>
      </ref>
      <ref id="cit0066">
        <label>66.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Muraja-Murro</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Kulkas</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Hiltunen</surname>
<given-names>M</given-names></string-name>, et al. <article-title>The severity of individual obstruction events is related to increased mortality rate in severe obstructive sleep apnea</article-title>. <source><italic toggle="yes">J Sleep Res</italic></source>. <year>2013</year>;<volume>22</volume>:<fpage>663</fpage>–<lpage>669</lpage>.<pub-id pub-id-type="pmid">23937311</pub-id></mixed-citation>
      </ref>
      <ref id="cit0067">
        <label>67.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Peker</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Glantz</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Eulenburg</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Wegscheider</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Herlitz</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Thunström</surname>
<given-names>E</given-names></string-name>. <article-title>Effect of Positive Airway Pressure on Cardiovascular Outcomes in Coronary Artery Disease Patients with Nonsleepy Obstructive Sleep Apnea. The RICCADSA Randomized Controlled Trial</article-title>. <source><italic toggle="yes">Am J Respir Crit Care Med</italic></source>. <year>2016</year>;<volume>194</volume>:<fpage>613</fpage>–<lpage>620</lpage>.<pub-id pub-id-type="pmid">26914592</pub-id></mixed-citation>
      </ref>
      <ref id="cit0068">
        <label>68.</label>
        <mixed-citation publication-type="journal"><string-name><surname>McEvoy</surname>
<given-names>RD</given-names></string-name>, <string-name><surname>Antic</surname>
<given-names>NA</given-names></string-name>, <string-name><surname>Heeley</surname>
<given-names>E</given-names></string-name>, et al. <article-title>SAVE Investigators and Coordinators. CPAP for Prevention of Cardiovascular Events in Obstructive Sleep Apnea</article-title>. <source><italic toggle="yes">N Engl J Med</italic></source>. <year>2016</year>;<volume>375</volume>:<fpage>919</fpage>–<lpage>931</lpage>.<pub-id pub-id-type="pmid">27571048</pub-id></mixed-citation>
      </ref>
      <ref id="cit0069">
        <label>69.</label>
        <mixed-citation publication-type="journal">Sánchez-de-la-Torre M, Sánchez-de-la-Torre A, Bertran S, et al. <article-title>Spanish Sleep Network. Effect of obstructive sleep apnoea and its treatment with continuous positive airway pressure on the prevalence of cardiovascular events in patients with acute coronary syndrome (ISAACC study): a randomised controlled trial</article-title>. <source><italic toggle="yes">Lancet Respir Med</italic></source>. <year>2020</year>;<volume>8</volume>:<fpage>359</fpage>–<lpage>367</lpage>.<pub-id pub-id-type="pmid">31839558</pub-id></mixed-citation>
      </ref>
      <ref id="cit0070">
        <label>70.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Heinzer</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Eckert</surname>
<given-names>D</given-names></string-name>. <article-title>Treatment for obstructive sleep apnoea and cardiovascular diseases: are we aiming at the wrong target?</article-title>
<source><italic toggle="yes">Lancet Respir Med</italic></source>. <year>2020</year>;<volume>8</volume>(<issue>4</issue>):<fpage>323</fpage>–<lpage>325</lpage>.<pub-id pub-id-type="pmid">31839559</pub-id></mixed-citation>
      </ref>
      <ref id="cit0071">
        <label>71.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Randerath</surname>
<given-names>W</given-names></string-name>, <string-name><surname>Bassetti</surname>
<given-names>CL</given-names></string-name>, <string-name><surname>Bonsignore</surname>
<given-names>MR</given-names></string-name>, et al. <article-title>Challenges and perspectives in obstructive sleep apnoea: report by an <italic toggle="yes">ad hoc</italic> working group of the Sleep Disordered Breathing Group of the European Respiratory Society and the European Sleep Research Society</article-title>. <source><italic toggle="yes">Eur Respir J</italic></source>. <year>2018</year>;<volume>52</volume>(<issue>3</issue>):<fpage>1702616</fpage>.<pub-id pub-id-type="pmid">29853491</pub-id></mixed-citation>
      </ref>
      <ref id="cit0072">
        <label>72.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Randerath</surname>
<given-names>WJ</given-names></string-name>, <string-name><surname>Herkenrath</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Treml</surname>
<given-names>M</given-names></string-name>, et al. <article-title>Evaluation of a multicomponent grading system for obstructive sleep apnoea: the Baveno classification</article-title>. <source><italic toggle="yes">ERJ Open Res</italic></source>. <year>2021</year>;<volume>7</volume>(<issue>1</issue>):<fpage>00928</fpage>–<lpage>2020</lpage>.<pub-id pub-id-type="pmid">33681346</pub-id></mixed-citation>
      </ref>
      <ref id="cit0073">
        <label>73.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Serino</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Cardoso</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Carneiro</surname>
<given-names>RJ</given-names></string-name>, et al. <article-title>OSA patients not treated with PAP - Evolution over 5 years according to the Baveno classification and cardiovascular outcomes</article-title>. <source><italic toggle="yes">Sleep Med</italic></source>. <year>2021</year>;<volume>88</volume>:<fpage>1</fpage>–<lpage>6</lpage>.<pub-id pub-id-type="pmid">34710706</pub-id></mixed-citation>
      </ref>
      <ref id="cit0074">
        <label>74.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Catalan Serra</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Soler</surname>
<given-names>X</given-names></string-name>. <article-title>Obstructive sleep apnea and cardiovascular events in elderly patients</article-title>. <source><italic toggle="yes">Expert Rev Respir Med</italic></source>. <year>2022</year>;<volume>16</volume>(<issue>2</issue>):<fpage>197</fpage>–<lpage>210</lpage>.<pub-id pub-id-type="pmid">35041560</pub-id></mixed-citation>
      </ref>
      <ref id="cit0075">
        <label>75.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Azarbarzin</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Sands</surname>
<given-names>SA</given-names></string-name>, <string-name><surname>Younes</surname>
<given-names>M</given-names></string-name>, et al. <article-title>The Sleep Apnea-Specific Pulse-Rate Response Predicts Cardiovascular Morbidity and Mortality</article-title>. <source><italic toggle="yes">Am J Respir Crit Care Med</italic></source>. <year>2021</year>;<volume>203</volume>(<issue>12</issue>):<fpage>1546</fpage>–<lpage>1555</lpage>.<pub-id pub-id-type="pmid">33406013</pub-id></mixed-citation>
      </ref>
      <ref id="cit0076">
        <label>76.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Betta</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Handjaras</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Ricciardi</surname>
<given-names>E</given-names></string-name>, et al. <article-title>Quantifying peripheral sympathetic activations during sleep by means of an automatic method for pulse wave amplitude drop detection</article-title>. <source><italic toggle="yes">Sleep Med</italic></source>. <year>2020</year>;<volume>69</volume>:<fpage>220</fpage>–<lpage>232</lpage>.<pub-id pub-id-type="pmid">32200309</pub-id></mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
